Why Cyclica exited: An honest answer
I’ve been overwhelmed and humbled by the number of people who have reached out with thoughtful and...
Naheed Kurji, Chief Executive Officer
Naheed Kurji is the Co-Founder, President and CEO of Cyclica. Naheed is passionate about building AI-augmented technologies that enable researchers to make more strategic and informed decisions in Healthcare and the life sciences. He spends the majority of his time obsessing over Cyclica’s culture, defining its strategy to best effect change in the pharma industry to achieve the company’s vision, and exploring opportunities for continued innovation.
The nexus between right and effective is where you win
Let’s face it, as business operators, technologists, scientists, and humans in general, we want to...
How Cyclica's Innovation fuels our success and continuous drive to tackle low data targets
Over the years, many aspects of Cyclica’s business and technology have changed, sometimes...
Response to Scripps Research Institute Paper on DCAF-1
A vast majority of protein targets in the human proteome have been deemed undruggable given the...
AI is not the Silver Bullet
As innovators, entrepreneurs, and operators, we have a responsibility to ensure that our...
Persevering through uncertainty
Like many venture-backed entrepreneurs and operators, I have been thinking about the relatively...
The Trailblazers of Innovation
I've now made my way through 5 of Walter Isaacson's books, including The Innovators, Steve Jobs,...
Flipping the (Drug Discovery) Problem on its Head with Polypharmacology
For context: medicines have traditionally been designed to target a single protein with high...
Building a neo-biotech: It's all in the (dream) team. Meet them
I’m often asked how I can lead a deep tech biotech company that’s at the intersection of AI,...
Neither AI nor HI are the silver bullet, but combined, they are
Recently, the Reproducibility Project: Cancer Biology published work that suggests that “more than...